SecBot SecBot
SC 13G ·Filed Nov 10, 2026

VIR

Vir Biotechnology, Inc.
NEUTRAL
Impact 3/10
Horizonimmediate Processed6d 15h ago SEC0000093751-26-000742
Passive investor 5%+ stake
Actionable Insight • Neutral

State Street's 4.6% stake is a routine passive holding by a large index/asset manager. The filing shows a reduction from the 12.4% stake BlackRock reported in October 2026, suggesting institutional rotation. Monitor upcoming 13F filings for broader institutional positioning ahead of Phase 3 ECLIPSE 1 data expected in Q4 2026.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+1
Entry
$13.15
T+0 close · Nov 10, 2026 · via day close
Latest settled
−0.15%
T+1 · $13.13
Vs SPY
−1.47%
α at T+1
Next horizon
T+5
in 6h
  1. T+0 · Nov 10 $13.15entry
  2. T+1 · 6d ago −0.15%α −1.47% · $13.13
  3. T+4 · todayOpen
  4. T+5 · in 6h Pending
  5. T+20 · in 22d Pending
  6. T+60 · in 3mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

State Street Corporation filed a Schedule 13G disclosing a 4.6% passive stake in Vir Biotechnology as of September 30, 2026, down from 12.4% reported by BlackRock in the prior 13G/A. This is a routine passive filing by a large asset manager with no activist intent.

Key Financial Metrics

Stake
4.6%
Investor
STATE STREET CORP

Key Facts

  • State Street Corp disclosed beneficial ownership of 7,822,781 shares of Vir Biotechnology common stock as of September 30, 2026
  • The stake represents 4.6% of shares outstanding
  • Filing certifies passive intent under Rule 13d-1(b) with no control intent
  • State Street is a large asset manager (custodian bank) filing as a parent holding company

Financial Impact

State Street holds 7.8M shares, approximately 4.6% of Vir Biotechnology's outstanding stock; at a $2.1B market cap this stake is worth roughly $97M

ownership

Risk Factors

  • No activist intent or control influence expected from this passive filing
  • Stake is below the 5% threshold that would require a 13G, but was filed voluntarily or due to aggregate group holdings

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
92% bullish (13 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
SC 13G Filing (Primary)0000093751-26-000742
Document: 0000093751-26-000742-index.html0000093751-26-000742
Document: 0000093751-26-000742.txt0000093751-26-000742

Track record

36 reports on VIR

Performance horizon

4 of 8 bullish or bearish reports moved the stock their way by T+5. Best: +29.79% at T+5 after the Nov 6, 2026 report. 5 of 9 went positive at some point.

Filters
  1. Nov 16, 2026today 424B5 Bearish 5/10 Entry $9.84 Now $9.58 +2.64% settles Nov 23
  2. Nov 13, 20263d ago 8-K Bearish 5/10 Entry $9.92 Now $9.58 +3.43% settles Nov 23
  3. Nov 12, 20264d ago 424B5 Bearish 5/10 Entry $9.96 Now $9.58 +3.82% settles Nov 20
  4. Nov 12, 20264d ago S-3ASR Neutral 3/10 Entry $9.96 Now $9.58 −3.82% settles Nov 20
  5. Nov 10, 20266d ago SC 13G Neutral 3/10 Viewing Entry $13.15 Now $9.58 −27.15% settles Nov 17
  6. Nov 9, 20267d ago 8-K Bullish 6/10 Entry $13.65 to $9.58 Now $9.58 −29.79% ▼ −29.79% −28.10% vs SPY
  7. Nov 6, 202610d ago SC 13D/A Bearish 5/10 Entry $13.65 to $9.58 Now $9.58 +29.79% ▲ +29.79% +28.10% vs SPY
  8. Nov 4, 202612d ago 8-K Neutral 5/10 Entry $11.02 to $12.12 Now $9.58 −13.07% ▲ +9.98% +6.69% vs SPY
  9. Nov 3, 202613d ago 144 Neutral 2/10 Entry $11.22 to $13.15 Now $9.58 −14.62% ▲ +17.20% +17.79% vs SPY
  10. Nov 2, 202614d ago 144 Neutral 1/10 Entry $11.00 to $13.65 Now $9.58 −12.91% ▲ +24.05% +23.97% vs SPY
Showing 10 of 36

US Market Status

Market Closed · Opens in 8h 24m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 10, 2026